Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, private Wegovy prices for weight loss vary by dose and provider, typically ranging from around £149 to £375 per month. That range reflects the graduated dose schedule — lower doses cost less, the maintenance dose more — and what each provider bundles into their fee. Wegovy is a prescription-only medicine that can only be supplied following a clinical assessment by a qualified prescriber; a legitimate price will always include that step, even if it isn't advertised as a separate line item.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching Wegovy weight loss prices are trying to answer a simple question: is this affordable, and is it worth it? That's a sensible place to start. What makes it tricky is that providers quote prices in different ways. Some advertise per-pen figures; others quote monthly; some bundle everything in and some add consultation fees, prescription charges and delivery on top. Two quotes that look similar on a comparison page can represent quite different total costs once you've clicked through.
The honest market context: Eli Lilly raised the UK list price of Mounjaro significantly from September 2025, and reported private market prices for semaglutide-based treatments like Wegovy have moved in a similar direction across the sector. If you want a breakdown of how those figures stack up, our guide to Wegovy weight loss pricing covers the dose-by-dose picture in detail. Wegovy's dose schedule (starting at 0.25 mg and titrated upward toward 2.4 mg or, for eligible patients, the newer 7.2 mg dose approved by the MHRA in April 2026) means your monthly outlay is likely to change as treatment progresses. Our dedicated Wegovy prices page walks through how the schedule affects overall cost across a treatment course.
Before treating any number as your real cost, it's worth confirming what it includes. A price that sits notably below the rest of the market deserves scrutiny rather than celebration, we'll come back to why.
There's no standard packaging rule for what a Wegovy price quote must include. Some providers charge separately for the initial consultation; others fold it in but add a prescription fee at checkout. Delivery charges (particularly for cold-chain medicines requiring tracked, temperature-controlled shipping) are sometimes quoted as add-ons. Follow-up clinical reviews before dose increases or repeat supplies are another variable: some services offer them as standard; others treat each contact as a chargeable event.
Aftercare matters more than it might seem. Wegovy is titrated gradually, and questions arise during that process, about side effects, missed doses, or whether a dose increase is appropriate. A service that doesn't include responsive clinical support effectively outsources those conversations to your GP, who may or may not be familiar with the treatment. Our page on the weight loss jab Wegovy price is a useful reference if you want to understand what a fully inclusive quote should look like compared to one that adds costs later. The full cost of Wegovy is worth thinking about across a full treatment course, not just the first pen.
If you're comparing two services and one is meaningfully cheaper, the gap usually lives somewhere in this list: no consultation fee shown, no delivery charge, no aftercare model, or (most seriously) no genuine clinical assessment at all. The MHRA has been explicit about the risks of medicines sold online without proper oversight; the MHRA's Yellow Card scheme exists partly for patients to report suspect sellers.
At nume, one price covers the consultation, the prescription, the medicine, next-working-day tracked delivery, and seven-day aftercare. There are no separate line items. If you order before 12pm on a working day and your consultation is approved, your treatment leaves the same day, useful if you're trying to time a delivery around your schedule. Nothing renews automatically; every repeat is clinically re-reviewed before it's issued.
We don't offer discount codes, and we don't run promotional pricing. That's a deliberate choice. Wegovy is a prescription medicine, not a consumer product, and price competition isn't the game we're playing. We're aware that puts us toward the higher end of some comparisons. What that buys is a service where a real prescriber reads every consultation, ID and weight are verified, and the supply chain runs through a GPhC-registered pharmacy you can check at the GPhC register (registration number 9012878). Current treatment pricing is shown on our treatment page, we keep it there rather than in body copy so it stays accurate as the market moves.
For a fuller picture of how Wegovy's results compare to what the treatment costs, our page on how much weight loss to expect on Wegovy covers the trial evidence in plain terms.
Wegovy is a prescription-only semaglutide treatment that can legally be supplied only by a registered pharmacy following a clinical assessment. When a price looks dramatically low, it's worth asking which parts of that process have been compressed or skipped. The MHRA has warned publicly about counterfeit and illegally sourced weight-loss pens circulating online (some containing insulin rather than semaglutide) seized in large quantities across 2024 and 2025. A small saving per pen is not a meaningful metric if the pen doesn't contain what it says on the label.
The safer test is clinical legitimacy: is the pharmacy GPhC-registered? Is there a genuine prescriber reviewing your medical history? Is the supply chain authorised? NICE's appraisal of semaglutide for weight management, TA875, sets the clinical standard for appropriate use, and appropriate use starts with proper assessment, not a fast checkout. If you'd like to explore treatment through a regulated service, our clinical team is ready to take your consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.